Rice Hall James & Associates LLC raised its stake in shares of MEDIFAST INC (NYSE:MED) by 22.9% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 40,117 shares of the specialty retailer’s stock after buying an additional 7,478 shares during the period. Rice Hall James & Associates LLC owned approximately 0.34% of MEDIFAST INC worth $1,664,000 as of its most recent filing with the SEC.

Other large investors have also added to or reduced their stakes in the company. Schwab Charles Investment Management Inc. raised its stake in MEDIFAST INC by 0.6% in the second quarter. Schwab Charles Investment Management Inc. now owns 42,990 shares of the specialty retailer’s stock valued at $1,783,000 after buying an additional 247 shares during the last quarter. HL Financial Services LLC raised its stake in MEDIFAST INC by 8.9% in the second quarter. HL Financial Services LLC now owns 8,806 shares of the specialty retailer’s stock valued at $365,000 after buying an additional 718 shares during the last quarter. TD Asset Management Inc. raised its stake in MEDIFAST INC by 4.1% in the second quarter. TD Asset Management Inc. now owns 30,600 shares of the specialty retailer’s stock valued at $1,269,000 after buying an additional 1,200 shares during the last quarter. Sei Investments Co. raised its stake in MEDIFAST INC by 95.9% in the second quarter. Sei Investments Co. now owns 3,922 shares of the specialty retailer’s stock valued at $163,000 after buying an additional 1,920 shares during the last quarter. Finally, Texas Permanent School Fund raised its stake in MEDIFAST INC by 1.5% in the second quarter. Texas Permanent School Fund now owns 8,185 shares of the specialty retailer’s stock valued at $339,000 after buying an additional 122 shares during the last quarter. 92.09% of the stock is owned by hedge funds and other institutional investors.

Shares of MEDIFAST INC (MED) opened at 52.03 on Wednesday. The stock’s 50 day moving average is $43.02 and its 200 day moving average is $43.49. The stock has a market cap of $620.72 million, a price-to-earnings ratio of 26.15 and a beta of 0.48. MEDIFAST INC has a 52-week low of $35.38 and a 52-week high of $52.37.

MEDIFAST INC (NYSE:MED) last released its earnings results on Tuesday, August 8th. The specialty retailer reported $0.63 EPS for the quarter, topping the Zacks’ consensus estimate of $0.53 by $0.10. MEDIFAST INC had a return on equity of 24.25% and a net margin of 8.62%. The firm had revenue of $75.70 million during the quarter, compared to the consensus estimate of $71.96 million. During the same quarter in the previous year, the company posted $0.63 earnings per share. The company’s revenue was up 6.5% compared to the same quarter last year. On average, equities analysts predict that MEDIFAST INC will post $2.12 EPS for the current fiscal year.

The company also recently announced a quarterly dividend, which was paid on Wednesday, August 9th. Investors of record on Friday, June 23rd were issued a dividend of $0.32 per share. This represents a $1.28 dividend on an annualized basis and a dividend yield of 2.46%. The ex-dividend date of this dividend was Wednesday, June 21st. MEDIFAST INC’s dividend payout ratio (DPR) is 64.32%.

WARNING: “Rice Hall James & Associates LLC Boosts Position in MEDIFAST INC (MED)” was first posted by The Cerbat Gem and is the property of of The Cerbat Gem. If you are accessing this news story on another site, it was stolen and republished in violation of United States and international copyright and trademark legislation. The legal version of this news story can be read at https://www.thecerbatgem.com/2017/08/16/rice-hall-james-associates-llc-boosts-position-in-medifast-inc-med.html.

Several research firms have recently commented on MED. BidaskClub raised shares of MEDIFAST INC from a “strong sell” rating to a “sell” rating in a research report on Friday, August 11th. Sidoti lowered shares of MEDIFAST INC from a “buy” rating to a “neutral” rating in a research report on Tuesday, May 2nd.

MEDIFAST INC Company Profile

Medifast, Inc is engaged in the production, distribution and sale of weight loss, weight management and healthy living products, and other consumable health and nutritional products. Medifast product lines include weight loss, weight management, and healthy living meal replacements, snacks, hydration products and vitamins.

Want to see what other hedge funds are holding MED? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MEDIFAST INC (NYSE:MED).

Institutional Ownership by Quarter for MEDIFAST INC (NYSE:MED)

Receive News & Stock Ratings for MEDIFAST INC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MEDIFAST INC and related stocks with our FREE daily email newsletter.